Association between bone mineral metabolism and vascular calcification in end-stage renal disease. 2022

Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
Kidney Center, Department of Medicine, Turku University Hospital, PL 52, Kiinamyllynkatu 4-8, 20521, Turku, Finland. louise.aaltonen@tyks.fi.

Development of vascular calcification is accelerated in patients with end-stage renal disease. In addition to traditional risk factors of cardiovascular disease (CVD) abnormal bone and mineral metabolism together with many other factors contribute to the excess cardiovascular burden in patients on dialysis. Aortic calcification score and coronary calcification score are predictive of CVD and mortality. The aim of this study was to evaluate the possible relationship between arterial calcification and bone metabolism. Thirty two patients on dialysis were included. All patients underwent a bone biopsy to assess bone histomorphometry and a 18F-NaF PET scan. Fluoride activity was measured in the lumbar spine (L1 - L4) and at the anterior iliac crest. Arterial calcification scores were assessed by computerized tomography for quantification of coronary artery calcification score and lateral lumbar radiography for aortic calcification score. This study group showed high prevalence of arterial calcification and 59% had verified CVD. Both CAC and AAC were significantly higher in patients with verified CVD. Only 22% had low turnover bone disease. There was a weak association between fluoride activity, which reflects bone turnover, measured in the lumbar spine, and CAC and between PTH and CAC. There was also a weak association between erosion surfaces and AAC. No significant association was found between calcification score and any other parameter measured. The results in this study highlight the complexity, when evaluating the link between bone remodeling and vascular calcification in patients with multiple comorbidities and extensive atherosclerosis. Several studies suggest an impact of bone turnover on development of arterial calcification and there is some evidence of reduced progression of vascular calcification with improvement in bone status. The present study indicates an association between vascular calcification and bone turnover, even though many parameters of bone turnover failed to show significance. In the presence of multiple other factors contributing to the development of calcification, the impact of bone remodeling might be diminished. The study is registered in ClinicalTrials.gov protocol registration and result system, ID is NCT02967042 . Date of registration is 17/11/2016.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
December 1995, Pediatric clinics of North America,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
October 2013, Hemodialysis international. International Symposium on Home Hemodialysis,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
January 2002, Journal of nephrology,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
October 2002, Clinical calcium,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
August 2002, JAMA,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
January 2015, Contributions to nephrology,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
January 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
January 2015, PloS one,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
August 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Louise Aaltonen, and Niina Koivuviita, and Marko Seppänen, and Heikki Kröger, and Xiaoyu Tong, and Eliisa Löyttyniemi, and Kaj Metsärinne
March 2019, Clinical case reports,
Copied contents to your clipboard!